Skip to main content
Caplight Logo









Neodocs

Neodocs

Private
MumbaiHealthcare & Life Scienceshttps://neodocs.in/

Last Round

Seed

Feb 8, 2024

Total Funding Raised

$2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Neodocs is a health technology company that provides smartphone-based medical testing solutions for at-home diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Computer Vision, Healthcare Analytics

Business Model

B2C

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

diagnostic test stripspoint-of-care testingat-home diagnosticssmartphone diagnosticscomputer visionhealth screeningbiomarker analysisdigital healthtelemedicinemedical deviceslab-on-a-chipremote patient monitoringRPMhealth techmHealth

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neodocs Comparables

Compare Neodocs with similar companies based on industry and business-model similarity.

Neodocs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vessel Health
81%
TestCard
80%
Vivoo
80%

Neodocs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 8, 2024
Pre SeedAug 25, 2021
Pre SeedDec 2, 2020

Key People

Founding team and executive leadership

Nikunj Malpani

Co-Founder CEO

Founding Team

Neodocs Investors

Notable investors and investment history

Neodocs investors
InvestorRounds
Omidyar Network IndiaSeed
Titan CapitalPre Seed, Seed
Titan CapitalSeed, Pre Seed
Y CombinatorSeed, Pre Seed
Prophetic VenturesPre Seed
100UnicornsSeed, Pre Seed
Gemba CapitalPre Seed, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 65% MoM, reaching 32.5K.

  • Oct 1, 2025

    Active projects and partners named in Philippines, Indonesia, Sri Lanka, Cameroon, and Nepal.

Neodocs Filings

Explore SEC and related filing metadata, where available.

Neodocs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Neodocs's valuation, stock price, and market status.

Is Neodocs a public or private company?

Neodocs is a private company.

What is the current stock price of Neodocs?

Neodocs is a private company with no public stock price. No recent secondary market data is available.

How much is Neodocs worth (valuation)?

Valuation information for Neodocs is not publicly available.

Can I buy Neodocs stock?

Neodocs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Neodocs's last funding round?

Neodocs's most recent funding round was Seed on February 8, 2024.

Who are the main investors in Neodocs?

Key investors in Neodocs include Omidyar Network India, Titan Capital, Y Combinator, 100Unicorns.

Will Neodocs IPO soon?

No public IPO plans have been announced for Neodocs.

How can I track Neodocs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neodocs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMumbai
Employee Range42
Year Founded2020
Last FundingFeb 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?